- Home
- ENS vs GH Comparison
ENS vs GH Comparison
Compare ENS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- GH
- Stock Information
- Founded
- ENS 1991
- GH 2011
- Country
- ENS United States
- GH United States
- Employees
- ENS N/A
- GH N/A
- Industry
- ENS Industrial Machinery/Components
- GH Medical Specialities
- Sector
- ENS Technology
- GH Health Care
- Exchange
- ENS Nasdaq
- GH Nasdaq
- Market Cap
- ENS 3.9B
- GH 3.0B
- IPO Year
- ENS N/A
- GH 2018
- Fundamental
- Price
- ENS $95.74
- GH $25.81
- Analyst Decision
- ENS Buy
- GH Strong Buy
- Analyst Count
- ENS 4
- GH 17
- Target Price
- ENS $120.00
- GH $39.31
- AVG Volume (30 Days)
- ENS 249.6K
- GH 2.2M
- Earning Date
- ENS 08-07-2024
- GH 11-04-2024
- Dividend Yield
- ENS 1.01%
- GH N/A
- EPS Growth
- ENS 29.52
- GH N/A
- EPS
- ENS 6.61
- GH N/A
- Revenue
- ENS $3,526,218,000.00
- GH $643,810,000.00
- Revenue This Year
- ENS $5.56
- GH $27.01
- Revenue Next Year
- ENS $4.15
- GH $18.30
- P/E Ratio
- ENS $14.38
- GH N/A
- Revenue Growth
- ENS N/A
- GH 26.20
- 52 Week Low
- ENS $83.27
- GH $15.81
- 52 Week High
- ENS $112.53
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- ENS 40.56
- GH 43.49
- Support Level
- ENS $97.86
- GH $23.48
- Resistance Level
- ENS $101.45
- GH $26.85
- Average True Range (ATR)
- ENS 1.85
- GH 1.15
- MACD
- ENS -0.02
- GH -0.13
- Stochastic Oscillator
- ENS 16.03
- GH 40.31
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers worldwide. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.